2020. Journal of Immunotherapy of Cancer
A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth

2019. Journal of Immunology Research
Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses In Vitro

2018. Journal of Immunology Research
Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy

2018. Oncotarget
Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy

2018. Cancer immunology, immunotherapy
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer

2013. Cancer Immunology and Immunotherapy
Immunological and Clinical Outcomes of DC-Vaccinated Melanoma Patients Are Associated with Increased Th1/Th17 and Reduced Th3 Cytokine Responses

2013. British Journal of Cancer
Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients

2013. Biological Research
TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer

2012. Cancer Immunology and Immunotherapy
Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients

2011. Clinical Cancer Research
Heat-Shock Induction of Tumor-Derived Danger Signals Mediate Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells

2009. Journal of Clinical Oncology
Prolonged Survival of Dendritic Cell–Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor B-Expressing T Cells

2007. Cytokine Growth Factor
Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape

2006. Immunobiology
The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines

2005. Clinical and Experimental Immunology
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients